GKCC LLC SCHEDULE 13G

Company

MiNK Therapeutics, Inc.

Filed

May 22, 2024

Accession Number

0001068238-24-000115

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →